Fenugreek Seed Extract (4-Hydroxyisoleucine)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Fenugreek Seed Extract (4-Hydroxyisoleucine).

Fenugreek seed extract functions as a glucose-dependent insulinotropic agent by modulating GLUT4 translocation and inhibiting alpha-amylase activity to improve glycemic control and metabolic homeostasis.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

440590

Molecular Weight

887.6 g/mol

XLogP3 (Lipophilicity)

-4.3

IUPAC Name

S-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 3-hydroxybenzenecarbothioate

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

Chromium Picolinate for enhanced insulin receptor sensitivity
Cinnamaldehyde for synergistic glucose transporter type 4 upregulation

Biological Formulation Enhancers

Piperine for inhibition of hepatic glucuronidation pathways
Galactomannan fibers for controlled intestinal release and improved saponin solubility

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Fenugreek Seed Extract (4-Hydroxyisoleucine) across standard consumer modalities.

💊 Standard Capsules

The hygroscopic nature of concentrated saponin extracts requires low-moisture HPMC capsules to prevent powder clumping and maintain shell integrity.

🍬 Gummy & Pectin Formats

The presence of sotolon creates a persistent, pungent maple-like aroma and bitter profile that necessitates complex masking agents and may interfere with pectin gelation kinetics.

🔬 Thin-Film Oral Strips

The high therapeutic dose required for metabolic efficacy significantly exceeds the standard 50mg payload capacity of thin-film polymer matrices.

For Brand Founders

Formulate with Fenugreek Seed Extract (4-Hydroxyisoleucine)

Ready to launch a product featuring Fenugreek Seed Extract (4-Hydroxyisoleucine)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Fenugreek Seed Extract (4-Hydroxyisoleucine) Bioavailability

Need absolute proof that your Fenugreek Seed Extract (4-Hydroxyisoleucine) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Fenugreek Seed Extract (4-Hydroxyisoleucine) Degradation Testing

Is your Fenugreek Seed Extract (4-Hydroxyisoleucine) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation